ArticleJournal of experimental & clinical cancer research : CR2018

ER-α36 mediates cisplatin resistance in breast cancer cells through EGFR/HER-2/ERK signaling pathway.

Linlin Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.